ZTS

NYSE · Pharmaceuticals

Zoetis Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$75.89

-2.82 (-3.58%)

As of Jun 22, 9:34 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 14 58%

Hold 10 42%

Sell 0 0%

Price Target

Analyst Price Target +176.5% upside

Low Target $137.04

Average Target $209.87

High Target $267.95

Current Price $75.89

Current
$75.89

Target
$209.87

$137.04 $209.87 avg $267.95

Scenario Analysis

Bear Case

$137.04

80.6%

Low target

Base Case

$209.87

+176.5%

Avg target

Bull Case

$267.95

+253.1%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$161.77

-53.1% from high

52-Week Low

$72.38

+4.8% from low

50-Day SMA

$124.55

-39.1% vs SMA

200-Day SMA

$142.48

-46.7% vs SMA

RSI (14)

62.1

Neutral

Target vs 52W High

$209.87

+29.7% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+20.7%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+29.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+37.9%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+35.2%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+219.0%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+176.5%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-32.3%